Splicing components play an essential role in mediating accurate and effi cient splicing. The complexity of the spliceosome and its regulatory networks increase the diffi culty of studying the splicing reaction in detail. Nuclear extracts derived from HeLa cells provide all of the obligatory components to carry out intron removal in vitro. This chapter describes the large-scale preparation of nuclear extract from HeLa cells.
Introduction
Crude, nuclear, and cytoplasmic extracts can be used to study the regulation of mRNA processing, such as transcription, premRNA splicing, and polyadenylation [ 1 -3 ] . As such, they can be used to evaluate molecular mechanisms and interactions through the use of immunoassays, mobility shift assays (EMSA), co-immunoprecipitation (Co-IP), and pull-down assays.
Analyzing pre-mRNA splicing cell-free has permitted to characterize the splicing machinery in detail [ 4 ] . Whole cell extracts can be used to support splicing in vitro [ 5 ] ; however, more than 60 % of the reaction volume has to be dedicated to whole cell extracts. Functional nuclear extracts, originally developed to study transcription in a test tube [ 6 ] , were fi rst applied to in vitro splicing reactions using β-globin minigenes [ 7 ] . Several modifi ed nuclear extract methods were reported since then [ 8 -11 ] , all of which contained all the components required for in vitro splicing of short pre-mRNAs synthesized in a separate transcription reaction [ 4 ] . Cytoplasmic S-100 extracts, a by-product of nuclear extract preparations, lack serine/ arginine (SR)-rich proteins and are therefore unable to support premRNA splicing unless they are supplemented with recombinant SR proteins [ 12 , 13 ] . HeLa cells are the most commonly used cells for the preparation of nuclear extract. Nevertheless, the following protocol is suitable for extract preparation from other cell lines as well.
Materials
Spinner cultured suspension HeLa-S3 cells (National Cell Culture Center) ( see Note 1 ).
1 M dithiothreitol (DTT).
2. 100 mM phenylmethanesulfonyl fl uoride (PMSF) in isopropanol.
3. 1× phosphate-buffered saline (PBS): 137 mM sodium chloride (NaCl), 2. 4. Swell the cells by adding hypotonic buffer to a fi nal volume of 3× PCV followed by incubating on ice for 10 min ( see Note 5 ).
5. Check for cell lysis of pre-dounced cells by staining a small aliquot of cells with trypan blue.
Cells

Reagents ( See Note 2 )
6. Lyse cells by douncing 10-20 plunges in Kontes-B (Wheaton) Dounce homogenizer (Pestle B) and pour into new bottles ( see Note 6 ).
7. Monitor the dounced cell lysis by staining a small aliquot of the cells with trypan blue.
8. Determine and record the packed nuclear volume (PNV) by centrifuging the cells at 3,300 × g for 15 min, then remove the supernatant. The supernatant can be saved for cytoplasmic S100 isolation preparation [ 10 ] .
9. Resuspend the pellet of nuclei by adding 0.5× PNV of low-salt buffer and transfer to glass beaker. Combine the nuclei into one beaker if there are multiple tubes.
10. Release the soluble proteins from the nuclei by adding 0.5× PNV of high-salt buffer drop-by-drop while gently stirring ( see Note 7 ).
11. Extract the nuclei on ice while stirring for 30 min.
12. Remove the nuclei by centrifuging at 25,000 × g for 30 min, and save the supernatant.
13. Desalt the nuclear extract by dialyzing the supernatant in dialysis tubing with more than 50× supernatant volume of dialysis buffer for 2-2.5 h while stirring.
14. Change the dialysis buffer and dialyze for an additional 2-2.5 h.
15. Remove the precipitate by centrifuging at 25,000 × g for 30 min, and then save the supernatant.
16. Aliquot the extract into 1 ml fractions and freeze on dry ice ( see Note 8 ).
17. Store the extracts at −80 °C ( see Note 9 ).
18. Validate the activity of the nuclear extracts with in vitro splicing (i.e., β-globin, Chapter 11 ).
4. This step needs to be carried out quickly because the hypotonic buffer swells the cells and could potentially break them. Consequently, proteins could leak out of the cell and be discarded with the supernatant.
5. The previous washing step using hypotonic buffer may already have initiated the swelling of the cells. Thus, the PCV may have increased. Refer only to the initial PCV that was recorded. For example, the PCV determined in step 2 is 15 ml, yet after step 3 it has increased to 25 ml. In step 4 add hypotonic buffer such that the fi nal volume of cells and buffer is 45 ml.
6. Perform the douncing with gentle strokes and the loose B pestle to ensure only the cell membranes, but not the nuclear membranes are disrupted.
7. The "drop-by-drop" action is important because rapidly increasing the salt concentration may lyse the nuclei. The lysate can be homogenized again by douncing if it is chunky.
8. 30 l of HeLa cell culture with a 4-6 × 10 5 cells/ml density would yield about 45 ml of nuclear extract. Every milliliter of nuclear extract should support ~130 (of 25 μl scale) splicing reactions at 30 % NE.
9. The freeze/thaw cycles should be limited to 5 times to avoid compromising extract activity. The non-disturbed extracts can be stored up to years at −80 °C without losing activity; however, the half-life at 4 °C is only 12 h [ 14 ] .
